Sharma Neha, Kar Anand, Panda Sunanda. Administration of Fenugreek Seed Extract Produces Better Effects in Glibenclamide-Induced Inhibition in Hepatic Lipid Peroxidation: An in vitro Study[J]. Chinese Journal of Integrative Medicine, 2019,25(4):278-284.
Sharma Neha, Kar Anand, Panda Sunanda. Administration of Fenugreek Seed Extract Produces Better Effects in Glibenclamide-Induced Inhibition in Hepatic Lipid Peroxidation: An in vitro Study[J]. Chinese Journal of Integrative Medicine, 2019,25(4):278-284.
Sharma Neha, Kar Anand, Panda Sunanda. Administration of Fenugreek Seed Extract Produces Better Effects in Glibenclamide-Induced Inhibition in Hepatic Lipid Peroxidation: An in vitro Study[J]. Chinese Journal of Integrative Medicine, 2019,25(4):278-284. DOI: 10.1007/s11655-015-1793-z.
Sharma Neha, Kar Anand, Panda Sunanda. Administration of Fenugreek Seed Extract Produces Better Effects in Glibenclamide-Induced Inhibition in Hepatic Lipid Peroxidation: An in vitro Study[J]. Chinese Journal of Integrative Medicine, 2019,25(4):278-284. DOI: 10.1007/s11655-015-1793-z.
Administration of Fenugreek Seed Extract Produces Better Effects in Glibenclamide-Induced Inhibition in Hepatic Lipid Peroxidation: An in vitro Study
摘要
Abstract
Objective:
2
To evaluate the comparative effects of fenugreek (
Trigonella foenum graecum
) seed extract (FSE) alone and in combination with an antidiabetic conventional medicine
glibenclamide (GLB)
on the inhibition of
in vitro
lipid peroxidation (LPO) in liver
the major target organ of a drug.
Methods:
2
LPO was induced by ferrous sulphate (FeSo
4
)
hydrogen peroxide (H
2
O
2
) and carbon tetrachloride (CCl
4
) and the effects of test seed extract and/or GLB were evaluated.
Results:
2
While FeSo
4
H
2
O
2
and CCl
4
markedly enhanced the hepatic LPO
simultaneous administration of FSE reduced it in a concentration dependent manner. However
when both FSE and GLB were added to the incubation mixture
chemically induced hepatic LPO was further inhibited. The test extract also exhibited high antioxidative activity in 1
FSE therapy in moderate concentration along with a hypoglycemic drug may prove to be advantageous in ameliorating diabetes mellitus and other diseases that are LPO mediated.